NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
46
VRTX Quote, Financials, Valuation and Earnings
Last price:
$401.14
Seasonality move
:
6.89%
Day range:
$386.49 - $401.31
52-week range:
$377.85 - $519.88
Dividend yield:
0%
P/E ratio:
25.59x
P/S ratio:
9.73x
P/B ratio:
6.55x
Volume:
6M
Avg. volume:
1.7M
1-year change:
-0.74%
Market cap:
$102.3B
Revenue:
$9.9B
EPS (TTM):
-$1.99
VRTX Analysts' Consensus Rating
The 31 analysts providing 12-month price projections for Vertex Pharmaceuticals shares anticipate an average target of $498.37, ranging from a low estimate of $325.00 to a high estimate of $602.00. This average target implies a growth of 25.42% compared to the current stock price of $397.27.
Consensus Price Target
$498.37
Highest Price Target
$602.00
Lowest Price Target
$325.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 14 | 17 | 17 |
| Hold | 8 | 11 | 12 |
| Sell | 2 | 2 | 2 |
| Consensus | Buy | Buy | Buy |
VRTX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 6.3% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 9.68% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.97% over the past day.
